Toujeo is a prescription medication used to manage blood sugar levels in adults with diabetes. The Toujeo TV spot, 'Blood Sugar Control Around the Clock', is an advertisement that highlights the advantages of using this medication.The commercial begins by showing a woman waking up in the middle of t...
Title: Toujeo TV Spot, 'Daily Groove: No Copay'Introduction:In the fast-paced world we live in, managing diabetes can sometimes feel like a hurdle. However, with the help of Toujeo, a groundbreaking diabetes medication, individuals can take control of their condition and lead an active lifestyle. To...
The Toujeo TV Spot titled 'Daily Groove' features a lively and uplifting message about how Toujeo can help you stay in your daily groove. The commercial starts with a man waking up and getting ready for his day, while upbeat music plays in the background.As he heads out the door, we see him go about...
TV Spot: 'Find Your Groove'Song: "September" by Earth, Wind & Fire[Scene: A bustling city street, filled with people walking briskly.]Narrator: Life is a constant dance, a rhythm that pulses through our veins. And with Toujeo, you can find your groove and keep it going.[Cut to a diverse group of ind...
The Toujeo TV spot titled 'Journal' is a heartwarming commercial that tells the story of a man keeping a journal to keep track of his diabetes. The 30-second ad starts with the man opening a notebook and writing in it with a pen. He then goes about his daily routine while carrying the journal with h...
Toujeo is a medication that is used to treat diabetes. It is a long-acting basal insulin, meaning it provides a steady release of insulin throughout the day to help control blood sugar levels. Toujeo is manufactured by Sanofi, a multinational pharmaceutical company based in France.
Approval and Significance:
Toujeo received approval from the U.S. Food and Drug Administration (FDA) in 2015 for use in adults with both type 1 and type 2 diabetes. It was considered a more potent follow-up to Sanofi's top-selling insulin product, Lantus. Toujeo was seen as an important medication in Sanofi's pipeline due to its potential to convert patients from Lantus as the older drug was about to lose U.S. patent protection.
Dosage and Usage:
Toujeo is available as a subcutaneous injection in a pre-filled pen device called SoloStar. It contains insulin glargine at a concentration of 300 units/mL. The dosing of Toujeo may vary depending on individual patient needs, and it is typically prescribed once daily. The injection should be administered at the same time each day, and the injection site should be rotated to avoid lipodystrophy.
Support and Savings:
Sanofi offers a support program for Toujeo called the Toujeo Savings & Support Program. This program may provide savings on eligible prescriptions for patients who are not covered by Medicare, Medicaid, VA, DOD, TRICARE, or any other government-funded healthcare program. Additional savings tips and coupons for Toujeo may be available through platforms like GoodRx.
Contacting Sanofi:
If you have any questions or would like to contact Sanofi directly, you can visit their website or use the contact form provided on their website.
It's important to note that the information provided is based on the search results and may not encompass all details about Toujeo or any updates since the search date. It is always advisable to consult healthcare professionals or refer to official sources for the most accurate and up-to-date information about any medication or company.